Takeda and Insilico Medicine sign a $600M AI drug discovery deal, adding to Insilico's growing portfolio of billion-dollar pharma partnerships in 2026.

Takeda and Insilico Medicine sign a $600M AI drug discovery deal, adding to Insilico's growing portfolio of billion-dollar pharma partnerships in 2026.

Insilico Medicine Announces Collaboration with Takeda to Advance Strategic AI Drug Discovery

Collaboration underlines surge in cross-border biotech licensing agreements